adenosine monophosphate has been researched along with Convalescence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andini, R; Bertolino, L; Corcione, A; Durante-Mangoni, E; Florio, LL; Mele, F; Murino, P; Zampino, R | 1 |
| Greger, J; Hartmann, W; Kluge, H; Wieczorek, V | 1 |
2 other study(ies) available for adenosine monophosphate and Convalescence
| Article | Year |
|---|---|
Early experience with remdesivir in SARS-CoV-2 pneumonia.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chemical and Drug Induced Liver Injury; Convalescence; Coronavirus Infections; COVID-19; Critical Illness; Darunavir; Drug Administration Schedule; Drug Combinations; Fatal Outcome; Humans; Hydroxychloroquine; Lopinavir; Multiple Organ Failure; Pandemics; Pneumonia, Viral; Ritonavir; RNA, Viral; SARS-CoV-2; Torsades de Pointes | 2020 |
[Course studies on cerebral glutamine excretion in schizophrenics under treatment with tranquilizing agents].
Topics: Acute Disease; Adenosine Monophosphate; Adenosine Triphosphate; Adult; Ammonia; Antipsychotic Agents; Brain; Convalescence; Female; Glutamine; Humans; Hydrolysis; Male; Phenothiazines; Remission, Spontaneous; Schizophrenia; Tranquilizing Agents | 1973 |